Holobiome Company
%20.jpg)
Owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety and other mental health problems including our metabolism and the immune response, enabling patients to recover quickly from their diseases easily without any pain and suffering.
Funding Status:
Seed
Industry:
Therapeutics
Technology:
NeuroTech
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
$10K
Last Funding Type:
Seed
Employee Number:
1-10
Investors Number:
2
Founded Date:
2015-01-01